TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA April 14, 1995
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Translational Research Needs Coordination, Budget, Advisors Say. Former SWOG Chairman Hoogstraten Publishes Memoir. June 23, 2006
